Literature DB >> 9833270

[Introduction of general hepatitis B vaccination in Switzerland].

H Zimmermann1, B Vaudaux, R Kammerlander.   

Abstract

The Swiss Federal Office of Public Health and the Advisory Board on Immunisation recommended that all adolescents aged 11 to 15 should be vaccinated against hepatitis B in December 1997. The introduction of universal immunisation is justified for epidemiological and economical reasons. Universal immunisation in no way excludes the immunisation of all persons exposed to a specific risk and the prenatal screening and immunisation of exposed newborns. Hepatitis B vaccines are safe and highly effective. The main reasons for this recommendation are summarised in the article.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9833270     DOI： 10.1007/BF02042179

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN： 0303-8408


  9 in total

1.  A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infants.

Authors:  P I Lee; C Y Lee; L M Huang; J M Chen; M H Chang
Journal:  Vaccine       Date:  1995-12       Impact factor: 3.641

Review 2.  Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination.

Authors:  D J West; G B Calandra
Journal:  Vaccine       Date:  1996-08       Impact factor: 3.641

3.  Overview of epidemiology and disease burden of hepatitis B in the European region.

Authors:  C Roure
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

4.  Assessment of a universal, school-based hepatitis B vaccination program.

Authors:  S Dobson; D Scheifele; A Bell
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

5.  Hepatitis B vaccination: protection for how long and against what?

Authors:  A J Hall
Journal:  BMJ       Date:  1993-07-31

6.  [General hepatitis B vaccination in Switzerland: what is the attitude of vaccinating physicians?].

Authors:  B Vaudaux; M A Steinemann
Journal:  Soz Praventivmed       Date:  1998

7.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

Authors:  D P Francis; S C Hadler; S E Thompson; J E Maynard; D G Ostrow; N Altman; E H Braff; P O'Malley; D Hawkins; F N Judson; K Penley; T Nylund; G Christie; F Meyers; J N Moore; A Gardner; I L Doto; J H Miller; G H Reynolds; B L Murphy; C A Schable; B T Clark; J W Curran; A G Redeker
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

8.  Twelve-year follow-up study of hepatitis B immunization of Senegalese infants.

Authors:  P Coursaget; D Leboulleux; M Soumare; P le Cann; B Yvonnet; J P Chiron; A M Coll-Seck; I Diop-Mar
Journal:  J Hepatol       Date:  1994-08       Impact factor: 25.083

9.  A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report.

Authors:  W Szmuness; C E Stevens; E A Zang; E J Harley; A Kellner
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.